May 18, 2024

Wegovy Cuts Risk of Heart Problems, Novo Nordisk Trial Says

A clinical trial was the first to demonstrate that a new obesity drug could also improve patients’ heart health.A clinical trial was the first to demonstrate that a new obesity drug could also improve patients’ heart health.Read MoreWegovy, Heart, Obesity, Semaglutide (Drug), Novo Nordisk A/S, Clinical Trials, Research, your-feed-science, your-feed-healthcareNYT > Health

Leave a Reply

Your email address will not be published. Required fields are marked *